<DOC>
	<DOCNO>NCT01370200</DOCNO>
	<brief_summary>The investigator want compare efficacy plasma exchange treatment use two different citrate ( 4 % 15 % ) anticoagulants plasma exchange treatment . The efficacy plasma exchange treatment well use 15 % trisodium citrate anticoagulant plasma exchange procedure .</brief_summary>
	<brief_title>Regional Citrate Anticoagulation Plasma Exchange Treatment</brief_title>
	<detailed_description>To compare elimination rate immunoglobulin plasma exchange treatment use two differently concentrate citrate anticoagulation plasma exchange procedure . At time want compare acid-base , electrolyte status anticoagulation protocol two citrate group .</detailed_description>
	<mesh_term>Glomerulosclerosis , Focal Segmental</mesh_term>
	<mesh_term>Guillain-Barre Syndrome</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>patient need plasma exchange treatment human albumins replacement fluid anemia Hb le 90</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>citrate</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>plasma exchange</keyword>
	<keyword>efficacy</keyword>
</DOC>